3ahealth is a Cypriot SME, specializing in the design and development of digital health systems and services. Its mission is to assist healthcare professionals and hospitals in optimizing clinical workflows for the benefit of citizens. Backed by a strong R&D portfolio, 3ahealth transforms research outcomes into commercial products by integrating 3rd party systems and AI models into its solutions. Over the years, 3ahealth participated in numerous national and European projects, where its contribution focuses on developing integrated digital health platforms that bring together AI tools, including medical imaging technologies, point-of-care technologies, and other medical systems, for collecting, processing, and visualizing data in ways that support clinical decision-making.
3ahealth’s flagship product, Alasia Health, (https://alasia.health/) is a cloud-based, interoperable, Software-as-a-Service (SaaS) Electronic Health Record (EHR), designed for use across diverse healthcare settings, from elderly care and rehabilitation centers to clinics and hospitals. Alasia Health is as a modular, plug-and-play platform that evolves through continuous R&D&I, offering features that address the real needs of both healthcare professionals and patients. Alasia Health is built based on international interoperability standards and requirements (EHDS regulation), such as the International Patient Summary (IPS) and ePrescription, implemented based on European projects outcomes for cross-border healthcare provision and certified by the IHE (Integrating Healthcare Enterprise) through the IHE- Connectathons. Alasia Health is paired with AlasiaGo, a healthcare professional app for optimizing in hospital clinical tasks, such as medication dispensation, food intake, vital signs acquisition, and many more. At the same time myAlasia app is designed to empower patients to co-manage their own health, have unobstructed access to their data, share their health data, and organize their care plan and hospital visits. The company has been awarded the Silver Label for the X-Share Yellow Button for myAlasia mobile app for secure, cross-border health data exchange. Alasia Health is also fully customizable to function as an electronic Case Report Form (eCRF) system.
Chrystalla Iosif (F) is a PhD graduate with a strong background in Genetics, genomics and systems biology. She holds a bachelor in Biological Sciences (University of Essex, 2012), a Master in Medical Genetics (Cyprus Institute of Neurology and Genetics, 2013), a Master in Genomics and Systems Biology (University of Gothenburg, 2017) and a PhD in Bioinformatics (University of Liverpool, 2023). She has acquired substantial laboratory experience, in an extensive range of methods and has developed the required skills to extract and analyse data using a repertoire of bioinformatics tools. She has experience in the training and supervision of students, overseeing their experiment assisting with troubleshooting and helping them to generate valid and statistically sound data. Dr. Iosif is currently working as a Project Manager and Data Analyst at 3ahealth, responsible for the coordination of the business analysis and software development teams and the timely and efficient implementation of research, development and innovation projects.